May D - Search Results

1

Ifosfamide, methotrexate and 5-fluorouracil for pretreated advanced breast cancer.

Becher R, Höfeler H, Kloke O, May D, Wandl U, Niederle N, Richter R, Scheulen ME, Schmidt CG. Becher R, et al. Among authors: may d. Oncology. 1991;48(6):459-63. doi: 10.1159/000226981. Oncology. 1991. PMID: 1749582

2

[Cardiac side effects of 5-fluorouracil].

May D, Wandl U, Becher R, Niederle N, Schmidt CG. May D, et al. Dtsch Med Wochenschr. 1990 Apr 20;115(16):618-21. doi: 10.1055/s-2008-1065055. Dtsch Med Wochenschr. 1990. PMID: 2328669 German.

3

Treatment of chronic myelogenous leukemia with interferons alpha and gamma.

Kloke O, May D, Wandl U, Becher R, Opalka B, Beer U, Niederle N. Kloke O, et al. Among authors: may d. Blut. 1990 Jul;61(1):45-6. doi: 10.1007/BF01739433. Blut. 1990. PMID: 2117476

4

Phase I study of recombinant human tumor necrosis factor alpha in advanced malignant disease.

Moritz T, Niederle N, Baumann J, May D, Kurschel E, Osieka R, Kempeni J, Schlick E, Schmidt CG. Moritz T, et al. Among authors: may d. Cancer Immunol Immunother. 1989;29(2):144-50. doi: 10.1007/BF00199290. Cancer Immunol Immunother. 1989. PMID: 2720707 Free PMC article.

5

[The dose of alpha interferon in induction and maintainance therapy of hairy cell leukemia].

Kloke O, May D, Wandl U, Niederle N. Kloke O, et al. Among authors: may d. Onkologie. 1988;11 Suppl 2:41-5. doi: 10.1159/000216578. Onkologie. 1988. PMID: 3065687 Clinical Trial. German.

6

[Refractory anemia with 5q--anomaly. Clinical picture and follow-up of seven patients].

May D, Becher R. May D, et al. Med Klin (Munich). 1992 Aug 15;87(8):408-11. Med Klin (Munich). 1992. PMID: 1406472 German.

7

Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders.

Wandl UB, Nagel-Hiemke M, May D, Kreuzfelder E, Kloke O, Kranzhoff M, Seeber S, Niederle N. Wandl UB, et al. Among authors: may d. Clin Immunol Immunopathol. 1992 Oct;65(1):70-4. doi: 10.1016/0090-1229(92)90250-r. Clin Immunol Immunopathol. 1992. PMID: 1382910

8

Interferon alfa-2b in acute- and chronic-phase chronic myelogenous leukaemia: initial response and long-term results in 54 patients.

Niederle N, Moritz T, Kloke O, Wandl U, May D, Becher R, Franz T, Opalka B, Schmidt CG. Niederle N, et al. Among authors: may d. Eur J Cancer. 1991;27 Suppl 4:S7-14. doi: 10.1016/0277-5379(91)90556-s. Eur J Cancer. 1991. PMID: 1799485

9

DNA-flow cytometry studies in blood and marrow cells from chronic myelogenous leukemia patients treated with interferon alpha-2b.

Wandl UB, May D, Peltzer T, Kloke O, Opalka B, Niederle N, Streffer C. Wandl UB, et al. Among authors: may d. Leuk Res. 1990;14(10):905-8. doi: 10.1016/0145-2126(90)90180-h. Leuk Res. 1990. PMID: 2259227

10

Treatment of chronic myelogenous leukemia with recombinant interferon alfa-2b.

Niederle N, Kloke O, May D, Becher R, Osieka R, Schmidt CG. Niederle N, et al. Among authors: may d. Invest New Drugs. 1987;5 Suppl:S19-25. doi: 10.1007/BF00207259. Invest New Drugs. 1987. PMID: 3474219

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

704 results

Search Page

Filters